Detalles de la búsqueda
1.
SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trial.
BMC Cancer
; 16(1): 780, 2016 10 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27724870
2.
Stabilized beta-catenin in thymic epithelial cells blocks thymus development and function.
J Immunol
; 182(5): 2997-3007, 2009 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19234195
3.
VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528.
Lung Cancer
; 79(1): 59-64, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23122759
Resultados
1 -
3
de 3
1
Próxima >
>>